Aker BioMarine First Quarter 2025 Earnings: US$0.023 loss per share (vs US$0.052 loss in 1Q 2024)

Simply Wall St

Aker BioMarine (OB:AKBM) First Quarter 2025 Results

Key Financial Results

  • Revenue: US$50.8m (up 4.7% from 1Q 2024).
  • Net loss: US$2.00m (loss narrowed by 51% from 1Q 2024).
  • US$0.023 loss per share (improved from US$0.052 loss in 1Q 2024).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

OB:AKBM Earnings and Revenue Growth May 2nd 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Aker BioMarine Earnings Insights

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 7.2% growth forecast for the Food industry in Norway.

Performance of the Norwegian Food industry.

The company's shares are up 2.5% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 1 warning sign for Aker BioMarine you should know about.

Valuation is complex, but we're here to simplify it.

Discover if Aker BioMarine might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.